The costs of caring: Medical costs of Alzheimer's disease and the managed care environment

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations

Abstract

This review summarizes the medical costs associated with Alzheimer's disease (AD) and related dementias, as well as the payers responsible for these medical costs in the US health care system. It is clear from this review that AD and related dementias are associated with substantial medical costs. The payers responsible for a majority of these costs are families of patients with AD and the US government through the Medicare and Medicaid programs. In an attempt to control expenditures, Medicare and Medicaid have turned to managed care principles and managed care organizations. The increase in "managed" dementia care gives rise to several potential problems for patients with AD, along with many opportunities for systematic improvement in the quality of dementia care. Evidence-based disease management programs provide the greatest opportunities for improving managed dementia care but will require the development of dementia-specific quality of care measures to evaluate and continually improve them.

Original languageEnglish (US)
Pages (from-to)168-178
Number of pages11
JournalJournal of Geriatric Psychiatry and Neurology
Volume14
Issue number4
DOIs
StatePublished - 2001

ASJC Scopus subject areas

  • Clinical Neurology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'The costs of caring: Medical costs of Alzheimer's disease and the managed care environment'. Together they form a unique fingerprint.

Cite this